Successful treatment and prevention of the recurrence of refractory vernal keratoconjunctivitis with dupilumab
Clin Exp Ophthalmol
.
2022 Dec;50(9):1100-1103.
doi: 10.1111/ceo.14142.
Epub 2022 Aug 16.
Authors
Mei-Chi Tsui
1
2
,
Bor-Luen Chiang
3
4
,
I-Jong Wang
1
5
Affiliations
1
Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
2
Department of Ophthalmology, An Nan Hospital, China Medical University, Tainan, Taiwan.
3
Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
4
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
5
Department of Ophthalmology, College of Medicine, National Taiwan University, Taipei, Taiwan.
PMID:
35907140
DOI:
10.1111/ceo.14142
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Conjunctivitis, Allergic* / drug therapy
Humans
Keratoconjunctivitis*
Substances
dupilumab
Antibodies, Monoclonal, Humanized